STXBP1 disorder clinical trial readiness study
Part of Brain & nervous system clinical trials.
This study is for people with a confirmed STXBP1 genetic change to help prepare for future clinical trials. It collects information about the condition to better understand it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a known STXBP1 genetic variant that is likely or definitely causing your symptoms
- You or your legal guardian must sign a consent form to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with STXBP1 or SYNGAP1 gene changes over time to learn more about how these conditions affect the body and mind. It does not test a treatment but helps researchers understand the natural course of the disorder.
This study looks at children with a confirmed STXBP1 genetic mutation to better understand the condition and find biological markers. It aims to help diagnose and treat the disease more effectively in the future.
This early-phase study tests how safe ETX101 is and whether it can help reduce seizures in young children with Dravet syndrome caused by an SCN1A gene change. It mainly enrolls infants and children with a specific type of seizure history and genetic result.
This study tests a new medicine (S230815) given by lumbar puncture (spinal tap) to see if it helps reduce seizures in children with a specific genetic cause of epilepsy. It is for children aged 2 to 12 who have not responded well to other treatments.
This study looks for genetic (inherited DNA) causes of epilepsy in children. It may help your family better understand what could be driving seizures, even if the cause isn’t known yet.
This study is creating a registry to track the health of people who have specific genetic changes that cause epilepsy and uncontrolled movements (dyskinesia). It may help researchers better understand these conditions and how they change over time.
Hear when a new STXBP1 Encephalopathy With Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.